$11.5 Billion is the total value of LANSDOWNE PARTNERS (UK) LLP's 125 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JUNO | Exit | JUNO THERAPEUTICS INC | $0 | – | -20,125 | -100.0% | -0.00% | – |
| ZLTQ | Exit | ZELTIQ AESTHETICS INC | $0 | – | -7,455 | -100.0% | -0.00% | – |
| ECA | Exit | ENCANA CORP | $0 | – | -48,005 | -100.0% | -0.01% | – |
| KO | Exit | COCA COLA CO | $0 | – | -27,630 | -100.0% | -0.01% | – |
| FIT | Exit | FITBIT INCcl a | $0 | – | -165,069 | -100.0% | -0.01% | – |
| CPS | Exit | COOPER STD HLDGS INC | $0 | – | -13,645 | -100.0% | -0.01% | – |
| MTCH | Exit | MATCH GROUP INC | $0 | – | -105,097 | -100.0% | -0.02% | – |
| RAI | Exit | REYNOLDS AMERICAN INC | $0 | – | -43,248 | -100.0% | -0.02% | – |
| FSLR | Exit | FIRST SOLAR INC | $0 | – | -84,838 | -100.0% | -0.02% | – |
| COG | Exit | CABOT OIL & GAS CORP | $0 | – | -236,558 | -100.0% | -0.05% | – |
| NEE | Exit | NEXTERA ENERGY INC | $0 | – | -46,078 | -100.0% | -0.05% | – |
| V | Exit | VISA INC | $0 | – | -1,423,851 | -100.0% | -0.99% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DELTA AIR LINES INC DEL | 38 | Q3 2023 | 25.1% |
| EATON CORP PLC | 33 | Q3 2023 | 11.6% |
| TAIWAN SEMICONDUCTOR MFG LTD | 25 | Q3 2023 | 17.9% |
| MANCHESTER UTD PLC NEW | 22 | Q3 2019 | 1.0% |
| SUMMIT THERAPEUTICS PLC | 22 | Q2 2020 | 0.6% |
| AMAZON COM INC | 21 | Q3 2023 | 13.9% |
| JPMORGAN CHASE & CO | 20 | Q1 2019 | 19.9% |
| CITIGROUP INC | 20 | Q4 2020 | 12.2% |
| FIRST SOLAR INC | 20 | Q3 2021 | 4.2% |
| UNITED TECHNOLOGIES CORP | 20 | Q1 2020 | 3.7% |
View LANSDOWNE PARTNERS (UK) LLP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Supernova Partners Acquisition Co II, Ltd. | February 14, 2022 | 2,152,911 | 6.2% |
| Summit Therapeutics plc | June 17, 2020 | 13,664,880 | 4.1% |
| Manchester United plcSold out | February 14, 2020 | 0 | 0.0% |
| CYTOKINETICS INC | January 30, 2018 | 2,647,981 | 4.9% |
| RESPONSE GENETICS INCSold out | February 12, 2016 | 0 | 0.0% |
View LANSDOWNE PARTNERS (UK) LLP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| SC 13G | 2023-02-08 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
View LANSDOWNE PARTNERS (UK) LLP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.